FeesSafety
Pluang+

First Mid Bancshares reports Q3 2026 net income of $33.3M and announces acquisition of Evergreen Bancshares.

Company Fundamentals
29 Oct 2026, 14:00 WIB
GlobeNewsWire
View Source
Bullish
First Mid Bancshares reports Q3 2026 net income of $33.3M and announces acquisition of Evergreen Bancshares.

First Mid Bancshares, Inc. reported a net income of $33.3 million for Q3 2026, with diluted EPS of $1.25, marking a strong quarter despite a slight decrease in total loans. The company announced the pending acquisition of Evergreen Bancshares, which will expand its presence in Missouri, Illinois, and Indiana and help surpass $10 billion in assets. Deposits increased slightly to $7.62 billion, while asset quality improved with lower criticized assets. The company also completed a sale of investment securities to reinvest at higher rates and declared a quarterly dividend of $0.26 per share.

First Mid Bancshares, Inc. announced its Q3 2026 results, showing a net income of $33.3 million. For readers following the Financials sector, here is Pluang's market snapshot as of Oct 29, 2026 17:11 WIB: out of 142 priced stocks, 80 rose and 56 fell. Notable movers include PURR at USD 9.61 with a 1-day change of -3.61%, LU at USD 7.88 down 3.55%, and ING at USD 31.86 down 3.15%.

More News

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...

Market News
Bullish
1 hour ago
Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...

Company Fundamentals
Bullish
1 hour ago
Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC have extended their partnership to include youth coach training, an annual Sports for All Summit, and sensory inclusion programs aimed at supporting neurodivergent children, especially those with ADHD, in...

Others
Bullish
2 hours ago
Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks announced that its CEO Adi Sfadia and CFO Gil Benyamini will attend the Deutsche Bank Global Space and Defense Tech Summit on November 18, 2026, in New York City. The event will feature one-on-one and group meetings, providin...

Market News
Neutral
2 hours ago
Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App